Position in PASG
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$233,712
-$815,142 QoQ
Shares Held
47,892
-64.2% QoQ
Ownership
1.49%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 30 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PASG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,951,130,026 across 312 Biotechnology names. PASG ranks #246 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in PASG
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $233,712 | 47,892 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,048,854 | 133,612 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,287,250 | 109,089 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $809,335 | 100,789 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $566,559 | 1,416,399 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $497,827 | 1,410,276 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $783,296 | 1,381,476 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $974,992 | 1,392,846 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $893,705 | 1,125,574 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,627,457 | 1,205,524 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,235,584 | 1,223,351 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $654,314 | 994,399 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $921,328 | 979,095 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $924,374 | 964,900 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,643,787 | 1,191,150 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,576,750 | 1,261,400 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,420,427 | 1,025,605 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,405,290 | 775,900 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,020,060 | 475,600 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,326,672 | 133,200 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $851,332 | 64,300 | Shares | Sole | 2021-08-13 | |
| 2020-09-30 | $330,372 | 25,200 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||